Hodgkin's disease after transplantation

Transplantation

Volumn 61, Issue 1, 1996, Pages 71-76

  Garnier, Jeanne Luce ^a   Lebranchu, Yvon ^b   Dantal, Jacques ^c   Bedrossian, Jeanine ^d   Cahen, Remi ^e   Assouline, David ^a   Jaccard, Arnaud ^d   Fetissoff, Frank ^b   Moreau, Anne ^c   Martin, Xavier ^a   Delsol, Georges ^f   Berger, Françoise ^a   Touraine, Jean Louis ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b CHU BRETONNEAU   (France)

^c HÔTEL DIEU   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; OKT 3; STEROID; VIRUS ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; GRAFT REJECTION; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION;

EID: 9044226535     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601150-00015     Document Type: Article

References (34)

1. Touraine JL, El Yafi S, Bosi E, et al. Immunoglobulin abnormalities and infectious lymphoproliferative syndrome (ILPS) in cyclosporine-treated patients. Transplant Proc 1983; 15: S2798.
2. Nalesnik MA, Jaffe R, Starlz TE, et al. The pathology of post-transplant lymphoproliferative disorders in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173.
3. Locker J, Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 1989; 135: 977.
4. Starlz TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1: 583.
5. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1991; 323: 1723.
6. Canfield CW, Hudnall SD, Colonna JO, et al. Fulminant Ep stein-Barr virus-associated post-transplant lymphoproliferative disorders following OKT3 therapy. Clin Transplant 1992; 6: 1.
7. Mueller N, Evans A, Harris NL, et al. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989; 320: 689.
8. Purtilo DT, Strobach RS, Okano M, Davis JR. Biology of disease. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992; 67: 5.
9. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320: 502.
10. Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991; 88: 4766.
11. Brousset P, Megetto F, Chittal S, et al. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease. Lab Invest 1993; 69: 483.
12. Deacon EM, Pallesen G, Niedobitek G, et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1992; 177: 339.
13. Delsol G, Brousset P, Chittal S, Rigal-Huguet F. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BAM HI-W probes in Hodgkin's disease. Am J Pathol 1992; 140: 247.
14. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320.
15. Klein G. Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 1989; 58: 5.
16. Ree HJ, Strauchen JA, Khan AA, et al. Human immunodeficiency virus-associated Hodgkin's disease. Cancer 1991; 67: 1614.
17. Audouin J, Diebold J, Pallesen G. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J Pathol 1992; 167: 381.
18. Uccini S, Monardo F, Ruco LP, et al. High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease. Lancet 1989; 1: 1458.
19. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323: 1767.
20. Cerilli J, Rynasiewicz JJ, Lemos LB, Rothermel WS. Hodgkin's disease in human renal transplantation. Am J Surg 1977; 133: 182.
21. Doyle TJ, Venkatachalam KK, Maeda K, Saeed SM, Tilchen EJ. Hodgkin's disease in renal transplant recipients. Cancer 1983; 51: 245.
22. Sterling WA, Wu LYF, Dowling EA, Diethelm AG. Hodgkin's disease in a renal transplant recipient. Transplantation 1974; 17: 315.
23. Oldhafer KJ, Bunzendahl H, Frei U, Kemnitz J, Vogt P, Pilchmayr R. Primary Hodgkin's lymphoma: an unusual cause of graft dysfunction after kidney transplantation. Am J Med 1989; 87: 218.
24. Fisher A, Blanche S, Le Bidois J, et al. Anti-B cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991; 324: 1451.
25. Urba WJ, Longo DL. Hodgkin's disease. N Engl J Med 1992; 326: 678.
26. MacLennan KA, Bennett MH, Tu A, et al. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. Cancer 1989; 64: 1686.
27. Brousset P, Knecht H, Rubin B, et al. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood 1993; 82: 872.
28. Murray RJ, Kurilla MG, Brooks JM, et al. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications or the immune control of EBV-positive malignancies. J Exp Med 1992; 176: 157.
29. Swinnen LJ. Increased risk of lymphoproliferative disorders following the use of OKT3: association with cumulative dose. In: Touraine JL, Traeger J, Betuel H, Dubernard JM, Revillard JL, Dupuy C, eds. Prevention and treatment of malignancies in transplantation. Dordrecht: Kluwer Academic Publishers, 1995.
30. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995; 59: 524.
31. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345: 1043.
32. Qunibi WY, Barri Y, Alfurayh O, et al. Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Transplant Proc 1993; 25: 1402.
33. Diehl V, Tesch H. Hodgkin's disease - environmental or genetic? N Engl J Med 1995; 332: 461.
34. Radl J. Age-related monoclonal gammapathies: clinical lessons from the aging C57 BL mouse. Immunol Today 1990; 11: 234.